Owlstone Medical LIMITED
England
- UEI
- FDLYKL86LUN8
- CAGE
- U1AX9
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- International Organization
- Corporate family
-
-
- Westport, CT GMVFDFWHFFM3
-
- SAM.gov registration date
- Physical address
- 183 Cambridge Science Park Milton Rd, Cambridge CB4 0GJ, UK
- Website
- owlstonemedical.com
- Founded
- 2004
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $1,950,600 |
| FY2024 | $41,665 |
| FY2023 | $2,088,788 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Breath biopsy collection station | Food and Drug Administration | $39,185 | |
| Breath sample collection mouthpiece | Naval Supply Systems Command (Navy) | $2,480 | |
| Defense innovation unit exhaled breath diagnostics prototype project | Washington Headquarters Service | $4,039,388 | |
| Reciva-RD breath sampler | Naval Supply Systems Command (Navy) | $22,962 |
Similar vendors
About the company
Owlstone Medical LIMITED is a UK-based for-profit limited liability company specializing in breath analysis technology for medical diagnostics. The company is a manufacturer of advanced breath sampling equipment and diagnostic technologies, with a focus on developing innovative solutions for both medical and defense applications. Registered in the System for Award Management (SAM) since April 2019, Owlstone Medical has established itself as a key provider of specialized breath analysis equipment to various U.S. federal agencies.
The company has secured multiple federal contract awards across defense and civilian agencies, demonstrating its versatility in providing breath-related diagnostic technologies. Notable contracts include a $5,265,714 Other Transaction Agreement with the Defense Threat Reduction Agency for the Defense Innovation Unit Exhaled Breath Diagnostics Prototype Project, which focuses on developing advanced breath-based diagnostic solutions with potential national security applications. Additionally, Owlstone Medical has received purchase orders from the U.S. Navy's Bureau of Medicine and Surgery for specific breath sampling equipment, including breath sample collection mouthpieces and the RECIVA-RD Breath Sampler. The most recent contract, a $39,185 purchase order from the Food and Drug Administration, involves the delivery of a Breath Biopsy Collection Station. Across these awards, the company has consistently worked on no set-aside contracts, indicating open competition and merit-based selection for its specialized breath analysis technologies.
Quick answers
Is Owlstone Medical LIMITED registered in SAM.gov?
Yes. Owlstone Medical LIMITED's SAM.gov registration is active through September 29, 2027.
How much has Owlstone Medical LIMITED received in federal contracts?
Federal contracts obligated $1,950,600 to Owlstone Medical LIMITED in fiscal year 2025 and $4,081,053 in fiscal years 2023 through 2027.
How does Owlstone Medical LIMITED rank among federal contractors?
Owlstone Medical LIMITED ranked #69 at the Defense Threat Reduction Agency in FY2025.
What is Owlstone Medical LIMITED's most recent federal award?
Owlstone Medical LIMITED's most recent federal contract award is Breath biopsy collection station (75F40124P00328), from Food and Drug Administration, on July 31, 2024.
On GovTribe
See Owlstone Medical LIMITED's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors